The Swiss pharmaceutical giant told patient groups tominersen didn't delay disease progression in one trial, while a study of ...

An update on the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington's ...

NAARDEN, Netherlands & WALTHAM, Mass. & BARCELONA, Spain, July 07, 2026--Prilenia Therapeutics B.V. and Ferreri today announced initiation of the confirmatory PRECISE-HD study (Pridopidine Phase 3 ...

Prilenia Therapeutics and Ferrer have begun the confirmatory Phase III PRECISE-HD clinical trial assessing pridopidine as a ...

A first-of-its-kind drug may slow the progression of Huntington's disease, a rare, fatal, neurodegenerative disorder.

A study conducted by the Sant Pau Research Institute (IR Sant Pau) and Hospital de Sant Pau has identified for the first time ...

Make time for The Boston-Dedham Pokemon & TCG Show on the Waltham Patch calendar ...

An update on the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington's disease was presented today at the ISSCR 2026 Annual Meeting.

Roche has halted development on two of its Huntington’s disease prospects, delivering another blow to a patient community that has long awaited new medicines. The Swiss drugmaker explained its ...

The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.

Huntington’s disease (HD) is one of those rare conditions that affects not just the patient but the entire family—medically, emotionally and genetically. This inherited brain disorder causes gradual ...

General Hospital drops a clue that left the fans believing that Britt’s Huntington’s disease might be fake. This happens when PCPD detective Joe Fitzpatrick investigates Britt and Rocco’s ...